Business Description
Genexine Inc
ISIN : KR7095700001
Compare
Compare
Traded in other countries / regions
095700.Korea IPO Date
2009-09-15Description
Genexine Inc is a clinical-stage biotechnology company. It is focused on the development and commercialization of immunotherapeutics and next-generation long-acting biologics. Its primary technologies are Therapeutic DNA vaccine technology and Hyfc platform. The company's product pipeline includes products such as GX-H9, GX-E2, GX-G3, GX-G6, and Papitrol-188 among others.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.7 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.26 | |||||
Debt-to-EBITDA | -2.06 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 1.69 | |||||
Beneish M-Score | -4.96 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -36.2 | |||||
3-Year FCF Growth Rate | -1.8 | |||||
3-Year Book Growth Rate | -22.8 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.73 | |||||
9-Day RSI | 46.99 | |||||
14-Day RSI | 50.05 | |||||
6-1 Month Momentum % | -16.06 | |||||
12-1 Month Momentum % | -29.66 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.23 | |||||
Quick Ratio | 1.23 | |||||
Cash Ratio | 0.96 | |||||
Days Sales Outstanding | 512.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.4 | |||||
Shareholder Yield % | 1.98 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -11.76 | |||||
Operating Margin % | -860.95 | |||||
Net Margin % | -972.07 | |||||
FCF Margin % | -634.64 | |||||
ROE % | -14.25 | |||||
ROA % | -11.02 | |||||
ROIC % | -10.83 | |||||
ROC (Joel Greenblatt) % | -30.99 | |||||
ROCE % | -12.04 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 68.42 | |||||
PB Ratio | 1.08 | |||||
Price-to-Tangible-Book | 1.09 | |||||
EV-to-EBIT | -8.23 | |||||
EV-to-EBITDA | -9.23 | |||||
EV-to-Revenue | 73.36 | |||||
EV-to-FCF | -11.56 | |||||
Price-to-Median-PS-Value | 1.23 | |||||
Earnings Yield (Greenblatt) % | -12.15 | |||||
FCF Yield % | -9.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genexine Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 4,320.835 | ||
EPS (TTM) (â‚©) | -999 | ||
Beta | 1.08 | ||
Volatility % | 42.8 | ||
14-Day RSI | 50.05 | ||
14-Day ATR (â‚©) | 369.005433 | ||
20-Day SMA (â‚©) | 7125 | ||
12-1 Month Momentum % | -29.66 | ||
52-Week Range (â‚©) | 5840 - 12300 | ||
Shares Outstanding (Mil) | 41.45 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Genexine Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Genexine Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Genexine Inc Frequently Asked Questions
What is Genexine Inc(XKRX:095700)'s stock price today?
The current price of XKRX:095700 is â‚©7140.00. The 52 week high of XKRX:095700 is â‚©12300.00 and 52 week low is â‚©5840.00.
When is next earnings date of Genexine Inc(XKRX:095700)?
The next earnings date of Genexine Inc(XKRX:095700) is .
Does Genexine Inc(XKRX:095700) pay dividends? If so, how much?
Genexine Inc(XKRX:095700) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |